G M Eliopoulos Selected Research

evernimicin

1/2001	In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis.
10/2000	In vivo activities of evernimicin (SCH 27899) against vancomycin-susceptible and vancomycin-resistant enterococci in experimental endocarditis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G M Eliopoulos Research Topics

Disease

5	Infections 12/2005 - 10/2000
3	Endocarditis 01/2001 - 06/2000
2	Body Weight (Weight, Body) 01/2001 - 10/2000
1	Communicable Diseases (Infectious Diseases) 03/2005
1	Peritonitis 07/2001
1	Superinfection 01/2001

Drug/Important Bio-Agent (IBA)

2	Anti-Infective Agents (Microbicides)IBA 12/2005 - 06/2000
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2005 - 01/2001
2	evernimicinIBA 01/2001 - 10/2000
2	Vancomycin FDA LinkGeneric 01/2001 - 10/2000
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 12/2005
1	Clindamycin (Cleocin)FDA LinkGeneric 12/2005
1	GlycopeptidesIBA 03/2005
1	Oxazolidinones (2 Oxazolidone)IBA 07/2001
1	Linezolid (Zyvox)FDA Link 07/2001
1	Methicillin (Metin)FDA Link 07/2001
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2001
1	sultamicillin (ampicillin-sulbactam)FDA LinkGeneric 01/2001
1	Oxacillin (Prostaphlin)FDA LinkGeneric 06/2000
1	taurolidineIBA 06/2000

Therapy/Procedure

2	Therapeutics 01/2001 - 10/2000
1	Aftercare (After-Treatment) 01/2001